Urinary small extracellular vesicles derived CCL21 mRNA as biomarker linked with pathogenesis for diabetic nephropathy

• Published in: Journal of translational medicine 2021-08, Vol.19 (1), p.355-355, Article 355
• Main Authors: Feng, Ye, Zhong, Xin, Ni, Hai-Feng, Wang, Cui, Tang, Tao-Tao, Wang, Li-Ting, Song, Kai-Yun, Tang, Ri-Ning, Liu, Hong, Liu, Bi-Cheng, Lv, Lin-Li
• Format: Article
• Language: English
• Subjects: Animals; Antibodies; Aquaporin 1; Aquaporin 2; Bioengineering; Biomarker; Biomarkers; Biopsy; CCL21; CCL21 protein; CD3 antigen; CD4 antigen; CD8 antigen; Cell organelles; Chemokine CCL21 - genetics; Chemokines; Correlation analysis; Creatinine; Cytokines; Development and progression; Diabetes; Diabetes mellitus; Diabetes Mellitus, Type 2 - complications; Diabetic nephropathies; Diabetic Nephropathies - diagnosis; Diabetic Nephropathies - genetics; Diabetic nephropathy; Diagnosis; Distal tubules; Epidermal growth factor receptors; Exosomes; Extracellular Vesicles; Gene expression; Genetic aspects; Health aspects; Humans; Infiltration; Inflammation; Kidney diseases; Lymphocytes T; Messenger RNA; Metabolism; Nephropathy; Pathogenesis; Proteinuria; Proximal tubules; Rats; Renal failure; Renal function; RNA, Messenger - genetics; Sclerosis; Urine
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-021-03030-x

Diabetic nephropathy (DN) is a leading cause of renal failure, whereas the effective and early diagnostic biomarkers are still lacking. Fourteen cytokines and chemokines mRNA were detected in urinary extracellular vesicles (EVs) from the screening cohort including 4 healthy controls (HC), 4 diabetes mellitus (DM) and 4 biopsy-proven DN patients, and was validated in another 16 HC and 15 DM and 28 DN patients. Correlation analysis was performed between the candidate biomarkers and clinic parameters as well as kidney histological changes. The findings were also confirmed in DN rat model with single injection of STZ. The number of small EVs secreted in urine was increased in DN patients compared to DM patients and healthy controls, with expression of AQP1 (a marker of proximal tubules) and AQP2 (a marker of distal/collecting tubules). Small EVs derived CCL21 mRNA increased significantly in DN patients and correlated with level of proteinuria and eGFR. Interestingly, elevated CCL21 mRNA from urine small EVs was observed in DN patients with normal renal function and could discriminate early DN patients from DM more efficiently compared to eGFR and proteinuria. CCL21 also showed an accurate diagnostic ability in distinguishing incipient from overt DN. Histologically, CCL21 mRNA expression increased progressively with the deterioration of tubulointerstitial inflammation and showed the highest level in nodular sclerosis group (class III) in DN patients. Remarkable infiltration of CD3 positive T cells including both CD4 and CD8 positive T cell population were observed in DN patients with high-CCL21 expression. Besides, accumulation of CD3 positive T cells correlated with level of urinary small EVs derived CCL21 and co-localized with CCL21 in the tubulointerstitium in DN patients. Finally, the correlation of CCL21 expression in renal cortex and urinary small EVs was confirmed in STZ-induced DN rat model. Urinary small EVs derived CCL21 mRNA may serve as early biomarker for identifying DN linked with pathogenesis. CCL21 mRNA mediated T cell infiltration may constitute the key mechanism of chronic inflammation in DN.